Showing results (271-280 of 392) with videos related to

Sort By:
Pageof 40
Haemostasis|July 27, 1999
Massive intracranial bleeding requiring emergency splenectomy in a patient with CMV-associated thrombocytopeniaA Gural, S Gillis, A Gafanovich, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1984
Biochemical comparison of murine colony-stimulating factors secreted by a T cell lymphoma and a myelomonocytic leukemiaR L Prestidge, J D Watson, D L Urdal, et al.
Blut|August 1, 1981
T-cell growth factor (interleukin 2) and terminal transferase activity in human leukemias and lymphoblastic cell linesR Mertelsmann, S Gillis, G Steinmann, et al.
Hepatology (Baltimore, Md.)|October 27, 1997
Transient immunosuppression with FK506 permits long-term expression of therapeutic genes introduced into the liver using recombinant adenoviruses in the ratY Ilan, V K Jona, K Sengupta, et al.
Blood|May 29, 2000
Induction of oral tolerance in splenocyte recipients toward pretransplant antigens ameliorates chronic graft versus host disease in a murine modelY Ilan, I Gotsman, M Pines, et al.
The Journal of Pathology|December 18, 2001
Immunomodulation of experimental colitis: the role of NK1.1 liver lymphocytes and surrogate antigens--bystander effectA Shlomai, S Trop, I Gotsman, et al.
Transplantation|July 15, 1997
Massive repopulation of rat liver by transplantation of hepatocytes into specific lobes of the liver and ligation of portal vein branches to other lobesY Ilan, N Roy-Chowdhury, R Prakash, et al.
The Journal of Clinical Investigation|March 1, 1997
Oral tolerization to adenoviral antigens permits long-term gene expression using recombinant adenoviral vectorsY Ilan, R Prakash, A Davidson, et al.
Vaccine|November 1, 1994
Improved immunogenicity in mice of a mammalian cell-derived recombinant hepatitis B vaccine containing pre-S1 and pre-S2 antigens as compared with conventional yeast-derived vaccinesD Shouval, Y Ilan, R Adler, et al.
Journal of Viral Hepatitis|November 22, 2014
Oral anti-CD3 immunotherapy for HCV-nonresponders is safe, promotes regulatory T cells and decreases viral load and liver enzyme levels: results of a phase-2a placebo-controlled trialW Halota, P Ferenci, D Kozielewicz, et al.
Pageof 40